Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 2001 Apr;54(4):272–274. doi: 10.1136/jcp.54.4.272

Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: diagnosis and treatment

T Baglin 1
PMCID: PMC1731401  PMID: 11304842

Abstract

Heparin induced thrombocytopenia thrombosis (HIT/T) is associated with a high morbidity and mortality. Diagnosis is essentially clinical and negative results of laboratory assays do not exclude the diagnosis. Treatment involves stopping all heparin immediately and giving an alternative thrombin inhibitor. The adoption of low molecular weight heparins is one reason for the reduced incidence of this disease in recent years.

Key Words: heparin induced thrombocytopenia • thrombosis • immune complexes • platelet aggregating factor

Full Text

The Full Text of this article is available as a PDF (77.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. I., Coats R., Liem T. K., Silver D. Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome. J Vasc Surg. 1998 Feb;27(2):309–316. doi: 10.1016/s0741-5214(98)70361-1. [DOI] [PubMed] [Google Scholar]
  2. Amiral J., Bridey F., Dreyfus M., Vissoc A. M., Fressinaud E., Wolf M., Meyer D. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992 Jul 6;68(1):95–96. [PubMed] [Google Scholar]
  3. Carlsson L. E., Santoso S., Baurichter G., Kroll H., Papenberg S., Eichler P., Westerdaal N. A., Kiefel V., van de Winkel J. G., Greinacher A. Heparin-induced thrombocytopenia: new insights into the impact of the FcgammaRIIa-R-H131 polymorphism. Blood. 1998 Sep 1;92(5):1526–1531. [PubMed] [Google Scholar]
  4. Chong B. H., Burgess J., Ismail F. The clinical usefulness of the platelet aggregation test for the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost. 1993 Apr 1;69(4):344–350. [PubMed] [Google Scholar]
  5. Chong B. H. Heparin-induced thrombocytopenia. Br J Haematol. 1995 Mar;89(3):431–439. doi: 10.1111/j.1365-2141.1995.tb08346.x. [DOI] [PubMed] [Google Scholar]
  6. Cines D. B., Tomaski A., Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987 Mar 5;316(10):581–589. doi: 10.1056/NEJM198703053161004. [DOI] [PubMed] [Google Scholar]
  7. Greinacher A., Amiral J., Dummel V., Vissac A., Kiefel V., Mueller-Eckhardt C. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion. 1994 May;34(5):381–385. doi: 10.1046/j.1537-2995.1994.34594249047.x. [DOI] [PubMed] [Google Scholar]
  8. Greinacher A., Völpel H., Janssens U., Hach-Wunderle V., Kemkes-Matthes B., Eichler P., Mueller-Velten H. G., Pötzsch B. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation. 1999 Jan 5;99(1):73–80. doi: 10.1161/01.cir.99.1.73. [DOI] [PubMed] [Google Scholar]
  9. Izban K. F., Lietz H. W., Hoppensteadt D. A., Jeske W. P., Fareed J., Bakhos M., Walenga J. M. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia. Semin Thromb Hemost. 1999;25 (Suppl 1):51–56. [PubMed] [Google Scholar]
  10. Jy W., Mao W. W., Horstman L. L., Valant P. A., Ahn Y. S. A flow cytometric assay of platelet activation marker P-selectin (CD62P) distinguishes heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT). Thromb Haemost. 1999 Oct;82(4):1255–1259. [PubMed] [Google Scholar]
  11. Kaplan K. L., Francis C. W. Heparin-induced thrombocytopenia. Blood Rev. 1999 Mar;13(1):1–7. doi: 10.1016/s0268-960x(99)90018-8. [DOI] [PubMed] [Google Scholar]
  12. Keeling D. M., Richards E. M., Baglin T. P. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia. Br J Haematol. 1994 Feb;86(2):425–426. doi: 10.1111/j.1365-2141.1994.tb04760.x. [DOI] [PubMed] [Google Scholar]
  13. Lee D. H., Warkentin T. E., Denomme G. A., Hayward C. P., Kelton J. G. A diagnostic test for heparin-induced thrombocytopenia: detection of platelet microparticles using flow cytometry. Br J Haematol. 1996 Dec;95(4):724–731. doi: 10.1046/j.1365-2141.1996.d01-1944.x. [DOI] [PubMed] [Google Scholar]
  14. Lewis B. E., Walenga J. M., Wallis D. E. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Semin Thromb Hemost. 1997;23(2):197–202. doi: 10.1055/s-2007-996091. [DOI] [PubMed] [Google Scholar]
  15. Magnani H. N. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172) Thromb Haemost. 1993 Oct 18;70(4):554–561. [PubMed] [Google Scholar]
  16. Petitou M., Hérault J. P., Bernat A., Driguez P. A., Duchaussoy P., Lormeau J. C., Herbert J. M. Synthesis of thrombin-inhibiting heparin mimetics without side effects. Nature. 1999 Apr 1;398(6726):417–422. doi: 10.1038/18877. [DOI] [PubMed] [Google Scholar]
  17. Polgár J., Eichler P., Greinacher A., Clemetson K. J. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients. Blood. 1998 Jan 15;91(2):549–554. [PubMed] [Google Scholar]
  18. Rhodes G. R., Dixon R. H., Silver D. Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations. Surg Gynecol Obstet. 1973 Mar;136(3):409–416. [PubMed] [Google Scholar]
  19. Slocum M. M., Adams J. G., Jr, Teel R., Spadone D. P., Silver D. Use of enoxaparin in patients with heparin-induced thrombocytopenia syndrome. J Vasc Surg. 1996 May;23(5):839–843. doi: 10.1016/s0741-5214(96)70246-x. [DOI] [PubMed] [Google Scholar]
  20. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol. 1997 Sep;98(3):648–656. doi: 10.1046/j.1365-2141.1997.2613077.x. [DOI] [PubMed] [Google Scholar]
  21. Visentin G. P., Ford S. E., Scott J. P., Aster R. H. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994 Jan;93(1):81–88. doi: 10.1172/JCI116987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Walenga J. M., Jeske W. P., Fasanella A. R., Wood J. J., Ahmad S., Bakhos M. Laboratory diagnosis of heparin-induced thrombocytopenia. Clin Appl Thromb Hemost. 1999 Oct;5 (Suppl 1):S21–S27. doi: 10.1177/10760296990050s105. [DOI] [PubMed] [Google Scholar]
  23. Walenga J. M., Jeske W. P., Wallis D. E., Bakhos M., Lewis B. E., Leya F., Fareed J. Clinical experience with combined treatment of thrombin inhibitors and GPIIb/IIIa inhibitors in patients with HIT. Semin Thromb Hemost. 1999;25 (Suppl 1):77–81. [PubMed] [Google Scholar]
  24. Walenga J. M., Jeske W. P., Wood J. J., Ahmad S., Lewis B. E., Bakhos M. Laboratory tests for heparin-induced thrombocytopenia: a multicenter study. Semin Hematol. 1999 Jan;36(1 Suppl 1):22–28. [PubMed] [Google Scholar]
  25. Warkentin T. E., Elavathil L. J., Hayward C. P., Johnston M. A., Russett J. I., Kelton J. G. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med. 1997 Nov 1;127(9):804–812. doi: 10.7326/0003-4819-127-9-199711010-00005. [DOI] [PubMed] [Google Scholar]
  26. Warkentin T. E., Hayward C. P., Boshkov L. K., Santos A. V., Sheppard J. A., Bode A. P., Kelton J. G. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood. 1994 Dec 1;84(11):3691–3699. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES